Procedural Advantages of a Novel Drug-Eluting Coronary Stent
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 814 participants.
Also called NCT02881216
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 814 participants
- Registry
-
NCT02881216
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02881216. Non-randomized; no masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2015-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Procedural Advantages of a Novel Drug-Eluting Coronary Stent
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Synergy Stent
- Intervention (Device)
- Currently common drug-eluting stent (DES)
- Lead sponsor
- University Hospital Heidelberg
Record details
- Record id
cardio:ct-nct02881216- Content hash
083c66228c45dd0b331253a89f71874db88ed55c1b5772ad0ec6f97e806b13bc